CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 519755-520524 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T65831","span":{"begin":0,"end":769},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies Perez-Garmendia Roxanna ⁎ ,2 , Ibarra-Bracamontes Vanessa 2 , Vasilevko Vitaly 1 , Luna-Muñoz Jose 3 , Mena Raul 3 , Govezensky Tzipe 2 , Manoutcharian Karen 2 , Cribbs David 1 , Gevorkian Goar 2 1 The Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, United States; 2 Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Mexico, Mexico; 3 Department of Neurosciences, CINVESTAV-IPN, Mexico, Mexico N-truncated/modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T157","span":{"begin":0,"end":769},"obj":"Sentence"}],"text":"Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies Perez-Garmendia Roxanna ⁎ ,2 , Ibarra-Bracamontes Vanessa 2 , Vasilevko Vitaly 1 , Luna-Muñoz Jose 3 , Mena Raul 3 , Govezensky Tzipe 2 , Manoutcharian Karen 2 , Cribbs David 1 , Gevorkian Goar 2 1 The Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, United States; 2 Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Mexico, Mexico; 3 Department of Neurosciences, CINVESTAV-IPN, Mexico, Mexico N-truncated/modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1144","span":{"begin":306,"end":324},"obj":"Phenotype"},{"id":"T1145","span":{"begin":674,"end":693},"obj":"Phenotype"},{"id":"T1146","span":{"begin":695,"end":697},"obj":"Phenotype"},{"id":"T1147","span":{"begin":766,"end":768},"obj":"Phenotype"}],"attributes":[{"id":"A1144","pred":"hp_id","subj":"T1144","obj":"http://purl.obolibrary.org/obo/HP_0002354"},{"id":"A1145","pred":"hp_id","subj":"T1145","obj":"http://purl.obolibrary.org/obo/HP_0002511"},{"id":"A1146","pred":"hp_id","subj":"T1146","obj":"http://purl.obolibrary.org/obo/HP_0002511"},{"id":"A1147","pred":"hp_id","subj":"T1147","obj":"http://purl.obolibrary.org/obo/HP_0002511"}],"text":"Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies Perez-Garmendia Roxanna ⁎ ,2 , Ibarra-Bracamontes Vanessa 2 , Vasilevko Vitaly 1 , Luna-Muñoz Jose 3 , Mena Raul 3 , Govezensky Tzipe 2 , Manoutcharian Karen 2 , Cribbs David 1 , Gevorkian Goar 2 1 The Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, United States; 2 Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Mexico, Mexico; 3 Department of Neurosciences, CINVESTAV-IPN, Mexico, Mexico N-truncated/modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3308","span":{"begin":329,"end":351},"obj":"Disease"},{"id":"T3309","span":{"begin":550,"end":553},"obj":"Disease"},{"id":"T3310","span":{"begin":600,"end":607},"obj":"Disease"},{"id":"T3311","span":{"begin":674,"end":693},"obj":"Disease"},{"id":"T3312","span":{"begin":695,"end":697},"obj":"Disease"},{"id":"T3313","span":{"begin":703,"end":718},"obj":"Disease"},{"id":"T3314","span":{"begin":766,"end":768},"obj":"Disease"},{"id":"T3286","span":{"begin":329,"end":351},"obj":"Disease"},{"id":"T3287","span":{"begin":550,"end":553},"obj":"Disease"},{"id":"T63478","span":{"begin":600,"end":607},"obj":"Disease"},{"id":"T24791","span":{"begin":674,"end":693},"obj":"Disease"},{"id":"T21721","span":{"begin":695,"end":697},"obj":"Disease"},{"id":"T17276","span":{"begin":703,"end":718},"obj":"Disease"},{"id":"T90906","span":{"begin":766,"end":768},"obj":"Disease"}],"attributes":[{"id":"A3308","pred":"mondo_id","subj":"T3308","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A3309","pred":"mondo_id","subj":"T3309","obj":"http://purl.obolibrary.org/obo/MONDO_0003455"},{"id":"A3310","pred":"mondo_id","subj":"T3310","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A3311","pred":"mondo_id","subj":"T3311","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A3312","pred":"mondo_id","subj":"T3312","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A3313","pred":"mondo_id","subj":"T3313","obj":"http://purl.obolibrary.org/obo/MONDO_0008608"},{"id":"A3314","pred":"mondo_id","subj":"T3314","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A32743","pred":"mondo_id","subj":"T3286","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A79395","pred":"mondo_id","subj":"T3287","obj":"http://purl.obolibrary.org/obo/MONDO_0003455"},{"id":"A73065","pred":"mondo_id","subj":"T63478","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A72153","pred":"mondo_id","subj":"T24791","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A24044","pred":"mondo_id","subj":"T21721","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A57923","pred":"mondo_id","subj":"T17276","obj":"http://purl.obolibrary.org/obo/MONDO_0008608"},{"id":"A85974","pred":"mondo_id","subj":"T90906","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies Perez-Garmendia Roxanna ⁎ ,2 , Ibarra-Bracamontes Vanessa 2 , Vasilevko Vitaly 1 , Luna-Muñoz Jose 3 , Mena Raul 3 , Govezensky Tzipe 2 , Manoutcharian Karen 2 , Cribbs David 1 , Gevorkian Goar 2 1 The Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, United States; 2 Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Mexico, Mexico; 3 Department of Neurosciences, CINVESTAV-IPN, Mexico, Mexico N-truncated/modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD."}